Page 273 - Tata_Chemicals_yearly-reports-2019-20

Integrated report Statutory reportS Financial StatementS
Consolidated

12. Other assets
` in crore
As at As at
March 31, 2020 March 31, 2019
Non-Current
(a) Capital advances 131.11 107.94
(b) Claim receivable 5.48 5.50
(c) deposit with public bodies and others 64.86 56.16
(d) prepaid expenses 28.41 24.54
(e) net defined benefit assets (note 40) 45.00 48.37
(f) others 10.46 9.89
285.32 252.40
Current
(a) prepaid expenses 43.28 59.98
(b) advance to suppliers 55.50 50.32
(c) Statutory receivables 285.03 202.37
(d) others 68.38 57.40
452.19 370.07

13. Inventories
` in crore
As at As at
March 31, 2020 March 31, 2019
(a) raw materials (footnote ‘i’) 740.59 619.80
(b) Work-in-progress 129.41 112.43
(c) Finished goods 664.10 594.62
(d) Stock-in-trade (footnote ‘i’) 87.25 125.34
(e) Stores, spare parts and packing materials (footnote ‘i’) 247.81 273.39
1,869.16 1,725.58
Footnotes:
(i) Inventories includes goods in transit:
(ii) the cost of inventories recognised as an expense includes ` 9.37 crore (2019: ` 8.64 crore) in respect of write-down of inventories to
net realisable value, and has been reduced by ` 3.66 crore (2019: ` 2.73 crore) in respect of reversal of such write-down. reversal of
previous write-downs have been largely as a result of increased selling prices of certain products.

(iii) Inventories have been offered as security against the working capital facilities provided by the bank.

271